Bile acid fractionations by high-performance liquid chromatography in equine liver disease.

The research article explores how bile acids are broken down in horses suffering from liver diseases and compares it to healthy controls, using a method called high-performance liquid chromatography (HPLC).

Research Objective

• The primary aim of the study was to ascertain the role of bile acids in horses suffering from liver diseases. Using HPLC, the researchers separated serum bile acids in 13 control horses and 8 horses with liver diseases.

Array of Heart Disease Assessment

• Diagnosis and classification of liver injury were performed based on histopathological examination of biopsy and/or autopsy samples.

Total Serum Bile Acid (tSBA) Determination

• The researchers measured the tSBA in both the control group and the disease group using two different methods – an enzymatic method (SBA-EA) and by accumulation of the bile acids (SBA-LC) fractionated by HPLC.
• Results showed that SBA-LC values were generally higher than SBA-EA values in both controls and liver disease cases, and did not exhibit a direct correlation.

Primary Bile Acid Findings

• The primary bile acids – total cholates and total chenodeoxycholates – were observed to account for most of the tSBA increase in liver disease cases.
• With the progression of liver injury, a shift was noticed in profile from taurocholate to free (unconjugated) cholate. This implies that the severity of liver damage can impact the form of bile acid present in the body.

Secondary Bile Acid Findings

• Among secondary bile acids, total deoxycholates and total taurodeoxycholates increased at random intervals, suggesting a non-linear relationship with liver disease progression.
• The data suggested that hepatocellular excretion might be the most sensitive step in the enterohepatic circulation of bile acids, influencing how they vary with liver disease severity.